These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24944151)

  • 1. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study.
    Sutton JM; Kooby DA; Wilson GC; Squires MH; Hanseman DJ; Maithel SK; Bentrem DJ; Weber SM; Cho CS; Winslow ER; Scoggins CR; Martin RC; Kim HJ; Baker JJ; Merchant NB; Parikh AA; Abbott DE; Edwards MJ; Ahmad SA
    J Gastrointest Surg; 2014 Sep; 18(9):1575-87. PubMed ID: 24944151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma.
    Abe T; Amano H; Hanada K; Minami T; Yonehara S; Hattori M; Kobayashi T; Fukuda T; Nakahara M; Ohdan H; Noriyuki T
    Anticancer Res; 2017 Oct; 37(10):5863-5870. PubMed ID: 28982913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
    Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
    Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative and long-term outcome after standard pancreaticoduodenectomy, additional portal vein and multivisceral resection for pancreatic head cancer.
    Kulemann B; Hoeppner J; Wittel U; Glatz T; Keck T; Wellner UF; Bronsert P; Sick O; Hopt UT; Makowiec F; Riediger H
    J Gastrointest Surg; 2015 Mar; 19(3):438-44. PubMed ID: 25567663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter in response to "Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study".
    Nanavati AJ
    J Gastrointest Surg; 2015 Feb; 19(2):407-8. PubMed ID: 25451731
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to the letter to the editor regarding manuscript entitled: "Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study".
    Sutton JM; Ahmad SA
    J Gastrointest Surg; 2015 Feb; 19(2):409-10. PubMed ID: 25451732
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma.
    Kneuertz PJ; Patel SH; Chu CK; Maithel SK; Sarmiento JM; Delman KA; Staley CA; Kooby DA
    Ann Surg Oncol; 2011 May; 18(5):1327-34. PubMed ID: 21369744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Weber CE; Bock EA; Hurtuk MG; Abood GJ; Pickleman J; Shoup M; Aranha GV
    J Gastrointest Surg; 2014 Feb; 18(2):340-7. PubMed ID: 24272772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis.
    Yao HS; Wang Q; Wang WJ; Hu ZQ
    World J Surg; 2008 Sep; 32(9):2038-46. PubMed ID: 18584239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of blood transfusion free pancreaticoduodenectomy to transfusion-eligible pancreaticoduodenectomy.
    Choi YY; Seo D; Choi D; Kim JH; Lee KJ; Ok SY
    Am Surg; 2011 Jan; 77(1):81-7. PubMed ID: 21396312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is total laparoscopic pancreaticoduodenectomy superior to open procedure? A meta-analysis.
    Zhang H; Lan X; Peng B; Li B
    World J Gastroenterol; 2019 Oct; 25(37):5711-5731. PubMed ID: 31602170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer.
    Dillhoff M; Yates R; Wall K; Muscarella P; Melvin WS; Ellison EC; Bloomston M
    J Gastrointest Surg; 2009 May; 13(5):825-30. PubMed ID: 19277793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
    Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.
    Roch AM; House MG; Cioffi J; Ceppa EP; Zyromski NJ; Nakeeb A; Schmidt CM
    J Gastrointest Surg; 2016 Mar; 20(3):479-87; discussion 487. PubMed ID: 26768008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.
    Snyder RA; Prakash LR; Nogueras-Gonzalez GM; Kim MP; Aloia TA; Vauthey JN; Lee JE; Fleming JB; Katz MHG; Tzeng CD
    HPB (Oxford); 2019 Jul; 21(7):841-848. PubMed ID: 30501986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Raut CP; Tseng JF; Sun CC; Wang H; Wolff RA; Crane CH; Hwang R; Vauthey JN; Abdalla EK; Lee JE; Pisters PW; Evans DB
    Ann Surg; 2007 Jul; 246(1):52-60. PubMed ID: 17592291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.
    Lopez-Aguiar AG; Ethun CG; Pawlik TM; Tran T; Poultsides GA; Isom CA; Idrees K; Krasnick BA; Fields RC; Salem A; Weber SM; Martin RCG; Scoggins CR; Shen P; Mogal HD; Beal EW; Schmidt C; Shenoy R; Hatzaras I; Maithel SK
    Ann Surg Oncol; 2019 Jun; 26(6):1814-1823. PubMed ID: 30877497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Gaujoux S; Torres J; Olson S; Winston C; Gonen M; Brennan MF; Klimstra DS; D'Angelica M; DeMatteo R; Fong Y; House M; Jarnagin W; Kurtz RC; Allen PJ
    Ann Surg Oncol; 2012 Sep; 19(9):2908-16. PubMed ID: 22411205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the necessity of transfusion during pancreatoduodenectomy.
    Ross A; Mohammed S; Vanburen G; Silberfein EJ; Artinyan A; Hodges SE; Fisher WE
    Surgery; 2013 Sep; 154(3):504-11. PubMed ID: 23972656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma?
    Khan S; Sclabas G; Reid-Lombardo K; Sarr MG; Nagorney D; Kendrick ML; Que FG; Donohue JH; Huebner M; Lohse C; Farnell MB
    J Gastrointest Surg; 2010 Nov; 14(11):1820-5. PubMed ID: 20676790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.